Our 2 hour critical appraisal and ASH review.  
SO many guest stars

2 HOUR ASH Presentation with AARON GOODMAN & MANNI & More

Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.

Alcohol - Is it healthy? Everything you need to know about Beer, Wine and Spirits

The entire healthcare system is broken, it's not just health insurance companies.

The ENTIRE healthcare system is broken, not just health insurance companies

I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more!

Trump's Big Health Care Changes: NIH study sections, MMWR gag order, WHO withdrawal & more!

I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more.

CIA says lab leak, Fauci's pardon, NIH's meetings, RFK Jr's hearing & more!

I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system.

Why the NIH is a broken funding system

I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints.

Elon's 6 Engineers/ Unelected/ RFK Jr/ MMR vaccines/ DEI/ USAID and NIH funding complaints

I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%.

Trump is breaking media brains / NIH cuts indirect payments and scientists freak out

I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya. 

RFK Jr takes office/ CDC layoffs/ Varmus criticizes Jay's proposal for Academic Freedom

CABINET - trial - Cabozantinib for NET

Welcome to season 2! We're starting this season off with a little bit of everything: a critique of the FDA's accelerated approval of selinexor for penta-refractory multiple myeloma; an interview with Dr. John Reneau of Ohio State University on ECHELON-2 (brentuximab vedotin in t-cell lymphomas); an interview with Dr. Michael Hayes of Kaiser Permanente on parachutes in medicine plus the relationship between conflict of interest and editorial stance on tumor-treating fields for glioblastoma multiforme; and an interview with Dr. Stacie Dusetzina - a leading researcher in health care policy and the cost of cancer drugs, and an avid Twitter user - of Vanderbilt University on #MedTwitter.

ECHELON-2: doi.org/10.1016/S0140-6736(18)32984-2
Facing Our Mistakes: doi.org/10.1056/NEJM198401123100211
Parachutes: doi.org/10.9778/cmajo.20170088
TTF: doi.org/10.1016/j.jcpo.2019.100189
Impact of Disclosing Financial Ties: doi.org/10.1001/archinternmed.2010.39

Back us on Patreon! www.patreon.com/plenarysession

July 2019

2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

2.01 Selinexor, ECHELON-2, Parachutes, Tumor-Treating Fields, & MedTwitter

Plenary Session - inactive due to federal service

Related tracks